Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-30 · accession 0001127602-24-017121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-31 | 2024-05-30 | BCRX | LEVIN ALAN G | Dir | P - Purchase | $6.36 | +7,861 | 45.0K | +21% | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-30 | P | A | 7,861 | $6.36 | 44,951 | D | — | — |